Navigation Links
Renowned Chinese Herbal Medicine Development Specialist Joins China Health Resources
Date:2/13/2008

SUINING, China, Feb. 13 /Xinhua-PRNewswire/ -- China Health Resources Co., Ltd. (CHRI; OTC Bulletin Board: CHRI) announced that Jia Minru, famous professor of the Chinese Medicine University and authoritative Chinese physician, joined CHRI recently to be responsible for deep development, high-tech development and systematic research of deep processed products of Chuan DAR GAP.

The joining of Jia Minru will certainly strengthen the research and development force of CHRI. With the technological advantage of CHRI, Jia will take part in realizing the commercial development with more advanced technology and more commercial value for Suining Chuan DAR and its processed products.

Jia has more than 40 years of research experience in medicine and herb resource development. He was the Advisor of the Chinese Medicine Academy, the Dean of Chinese Medicine University, the deputy dean of Chinese Medicine Association, Director of Chinese Medicine and Herb Committee, and a Member of Sichuan New Medicine Assessment Center.

About the Company

China Health Resources Co., Ltd. (CHRI) was incorporated on April 24, 2001. It is one of China's leading industrialized agricultural corporations. CHRI focuses on the production and further processing of Dahurian Angelica Root (DAR), a herb that is widely used in China, and considered to be an important ingredient in Chinese traditional medicine. CHRI's business plan includes distributing DAR and its processed products to exploit a large market in the areas of treatment of pain, swelling and pustule. Good Agricultural Practice (GAP) is a national compulsory criterion for food and drug industries. The goal of GAP is to help agricultural product companies deal with the usual micro-organism harm so as to enhance safety of agricultural products. CHRI has accomplished GAP certification of Chuan DAR, making DAR products and related production technology of the Company part of the industry criteria.

Statements regarding financial matters in this press release other than historical facts are 'forward-looking statements' within the meaning of section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The company intends that such proclamations about future expectations, including future revenues and earnings and all other forward-looking statements be subject to the safe harbors created thereby. CHRI depends on outside resources to maintain its continuation. Since these statements involve risks and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results.

For more information, please contact:

Office of CHRI

Tel: +86-825-239-1788

343 Suining Zhong Road, Suining, Sichuan, P.R. China

Website: http://www.chinahealthresource.com


'/>"/>
SOURCE China Health Resources Co., Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Cleveland Clinic Recruits World Renowned Heart Rhythm Specialist to Direct Electrophysiology
2. Childrens Hospital Boston Mourns the Death of Dr. Judah Folkman, World Renowned Researcher and Founder of the Field of Angiogenesis
3. HealthONE(R) Appoints Nationally Renowned Pediatric Cardiologist & Childhood Obesity Expert as First Chief Medical Officer for the Rocky Mountain Hospital for Children(SM)
4. BREATHE Lung Cancer Conference, Nov. 30, Attracts World Renowned Physicians and Speakers
5. World-Renowned Therapist Joins The Center for Children and Families In Its Work With the Nations Poorest Families
6. Thailand: Partners Open Free AIDS Treatment Clinic in Renowned AIDS Temple in Lop Buri
7. China Pharma Holdings, Inc. Receives Chinese SFDA Approval for Generic Bumetanide Injection
8. Linkwell Chairman & CEO Addresses the Association of Chinese Nosocomial Infections Professional Committee
9. What are the essential characteristics of serum PG in Chinese?
10. Rh-Apo2L Named as One of Chinas High-Tech Transforming Products by Chinese Government
11. All-State Properties, L.P. Announces Termination of Reverse Merger With Chinese Pharmaceutical Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... ... May 31, 2016 , ... Splashtop Inc., the worldwide leader in ... Networks Co., the leading provider of secure mobile remote access solution for Japan ... leading CACHATTO remote access solution. Splashtop for CACHATTO will be available as ...
(Date:5/31/2016)... ... May 31, 2016 , ... The ... advanced Artificial Intelligence (AI) and the latest in Clinical Patient Pod ... integrating predictive analytic outputs directly into the clinical workflow. These insights are empowering ...
(Date:5/31/2016)... Maryland (PRWEB) , ... May 31, 2016 , ... ... to attribute calls back to particular advertising campaigns, to monitor the performance of ... that they can maximize conversions and revenue. The software allows customers to record, ...
(Date:5/31/2016)... ... 31, 2016 , ... The successful implementation of “lean manufacturing” in various fields ... laboratories have different challenges compared to manufacturing environments. , In order to provide ... TOLEDO has developed the Lean Lab Checklist . This checklist will help users ...
(Date:5/31/2016)... San Francisco, CA (PRWEB) , ... May 31, 2016 , ... ... and cases for digital-minded professionals, announces the waxed-canvas and leather Duo Dopp Kit ... lightweight, durable waxed canvas or ballistic nylon, the Duo is smartly designed ...
Breaking Medicine News(10 mins):
(Date:5/30/2016)... -- On 28 May, 194 Member States made ... the 69 th World Health Assembly, governments unanimously voted ... the greatest global commitment in viral hepatitis to date. ... and C by 2030 and includes a set of prevention ... by 65% and increase treatment to 80%, saving 7.1 million ...
(Date:5/30/2016)... 2016 LifeScienceIndustryResearch.com adds "Ulcerative ... report with comprehensive information on the therapeutic development ... various stages, therapeutics assessment by drug target, mechanism ... molecule type, along with latest updates, and featured ... players involved in the therapeutic development for Ulcerative ...
(Date:5/27/2016)... -- A new study highlights the necessity of health literacy within the technology advancement of ... of Radiology , a majority of oncology patients undergo imaging screenings without understanding the ... ... ... Medical Diagnostic Imaging Ampronix ...
Breaking Medicine Technology: